Cancer Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Cancer stocks.

Cancer Stocks Recent News

Date Stock Title
May 17 AEZS Aeterna Zentaris Finalizes Some Details for Ceapro Merger
May 17 AEZS Aeterna Zentaris Announces Details Regarding Transaction with Ceapro
May 16 AFL Aflac (AFL) to Acquire 40% Stake in Tree Line Capital for $100M
May 16 AIM AIM ImmunoTech Inc. (AIM) Q1 2024 Earnings Call Transcript
May 16 AFL Aflac agrees to buy 40% stake in private-credit shop Tree Line Capital
May 16 AFL Aflac Global Investments to acquire stake in private credit asset management firm Tree Line Capital Partners
May 16 AIM AIM ImmunoTech GAAP EPS of -$0.12
May 16 AGEN FDA Grants Agenus Type B End-of-Phase 2 Meeting to Discuss BOT/BAL Therapy for Relapsed or Refractory Metastatic Colorectal Cancer
May 16 AIM AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 15 AFL Aflac Is Buying a Stake in a Direct Lender, Getting a Piece of the Private Credit Boom
May 15 AIM AIM ImmunoTech Q1 2024 Earnings Preview
May 15 AEMD Aethlon Medical announces pricing of $4.7 million public offering
May 15 ALLR Allarity Therapeutics reports Q1 GAAP EPS of -$22.14
May 15 AEMD Aethlon Medical Announces Pricing of $4.7 Million Public Offering
May 15 ALLO Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15 AEMD Why Arcutis Biotherapeutics Shares Are Trading Higher By 29%; Here Are 20 Stocks Moving Premarket
May 15 AEZS Aeterna Zentaris GAAP EPS of -$4.74
May 15 AEZS MT Newswires Canada Overnight Stocks To Watch: Aeterna Zentaris; Orla Mining; Andlauer Healthcare; CES Energy Solutions; Imperial Metals; Sulliden
May 14 AEZS Aeterna Zentaris Reports First Quarter 2024 Financial Results
May 14 ALLR Allarity Therapeutics Reports First Quarter Financial Results and Highlights, including Clear Clinical Benefits from Phase 2 Trial, NASDAQ Compliance, and Significant Improvement in Cash and Equity Balances
Cancer

Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body. These contrast with benign tumors, which do not spread to other parts of the body. Possible signs and symptoms include a lump, abnormal bleeding, prolonged cough, unexplained weight loss and a change in bowel movements. While these symptoms may indicate cancer, they may have other causes. Over 100 types of cancers affect humans.Tobacco use is the cause of about 22% of cancer deaths. Another 10% are due to obesity, poor diet, lack of physical activity or excessive drinking of alcohol. Other factors include certain infections, exposure to ionizing radiation and environmental pollutants. In the developing world, 15% of cancers are due to infections such as Helicobacter pylori, hepatitis B, hepatitis C, human papillomavirus infection, Epstein–Barr virus and human immunodeficiency virus (HIV). These factors act, at least partly, by changing the genes of a cell. Typically, many genetic changes are required before cancer develops. Approximately 5–10% of cancers are due to inherited genetic defects from a person's parents. Cancer can be detected by certain signs and symptoms or screening tests. It is then typically further investigated by medical imaging and confirmed by biopsy.Many cancers can be prevented by not smoking, maintaining a healthy weight, not drinking too much alcohol, eating plenty of vegetables, fruits and whole grains, vaccination against certain infectious diseases, not eating too much processed and red meat and avoiding too much sunlight exposure. Early detection through screening is useful for cervical and colorectal cancer. The benefits of screening in breast cancer are controversial. Cancer is often treated with some combination of radiation therapy, surgery, chemotherapy and targeted therapy. Pain and symptom management are an important part of care. Palliative care is particularly important in people with advanced disease. The chance of survival depends on the type of cancer and extent of disease at the start of treatment. In children under 15 at diagnosis, the five-year survival rate in the developed world is on average 80%. For cancer in the United States, the average five-year survival rate is 66%.In 2015, about 90.5 million people had cancer. About 14.1 million new cases occur a year (not including skin cancer other than melanoma). It caused about 8.8 million deaths (15.7% of deaths). The most common types of cancer in males are lung cancer, prostate cancer, colorectal cancer and stomach cancer. In females, the most common types are breast cancer, colorectal cancer, lung cancer and cervical cancer. If skin cancer other than melanoma were included in total new cancer cases each year, it would account for around 40% of cases. In children, acute lymphoblastic leukemia and brain tumors are most common, except in Africa where non-Hodgkin lymphoma occurs more often. In 2012, about 165,000 children under 15 years of age were diagnosed with cancer. The risk of cancer increases significantly with age, and many cancers occur more commonly in developed countries. Rates are increasing as more people live to an old age and as lifestyle changes occur in the developing world. The financial costs of cancer were estimated at $1.16 trillion USD per year as of 2010.

Browse All Tags